Patents by Inventor Edgar Selzer

Edgar Selzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inhibiting tumor growth
    Patent number: 7851462
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: December 14, 2010
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Treatment of Diabetes by at Least One Epidermal Growth Factor Receptor Specific Antibody or a Derivative Thereof
    Publication number: 20100034816
    Abstract: The present invention relates to the use of at least one epidermal growth factor receptor specific antibody or a derivative thereof for the manufacture of a medicament for the treatment of diabetes, in particular of the advanced insulin-dependent stage of diabetes mellitus Type 1 and 2 in humans as well as in animals.
    Type: Application
    Filed: December 21, 2007
    Publication date: February 11, 2010
    Applicant: NOVELIX THERAPEUTICS GMBH
    Inventors: Edgar Selzer, Gabriela Kornek
  • METHODS AND COMPOSITIONS FOR INHIBITING TUMOR GROWTH
    Publication number: 20080214516
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: December 21, 2007
    Publication date: September 4, 2008
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Methods and compositions for inhibiting tumor growth
    Patent number: 7312205
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: December 25, 2007
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Medicament for inhibiting tumour growth
    Publication number: 20060194774
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: February 11, 2004
    Publication date: August 31, 2006
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke